ArticlePain2026
Dual-frequency spinal cord stimulation increases responder rates for treatment of neuropathic pain.
Article in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
abstractSpinal cord stimulation (SCS) is an established treatment for chronic pain. However, there is a clear opportunity for improvement as only approximately 60% of patients report a 50% or greater reduction in pain. In this study, we propose a novel approach, termed dual-frequency spinal cord stimulation (dfSCS), that is designed to exploit the underlying putative mechanisms of SCS-Gate Control Theory-by dispersing SCS-mediated excitation in time while preserving SCS-mediated inhibition. We simulate dfSCS, using a validated computational model of the spinal cord dorsal horn, by delivering 2 simultaneous stimulation frequencies to Aβ dorsal column axons representing the painful and surrounding region dermatomes. We experimentally compared dfSCS patterns that the model indicated were robust to variation in the axonal populations activated, as well as progressive loss of GABAergic inhibition typical in chronic pain, against conventional single-frequency SCS in male spared nerve injured rats. Dual-frequency spinal cord stimulation targeted to vertebral levels T12/T13, where the largest population of dorsal column projections from the hypersensitive sural nerve territory and surrounding dermatomes are located, increased responder rates over conventional stimulation. The optimal dfSCS frequency combination depended on both the orientation of the bipolar electrode stimulation and the rostrocaudal placement over the cord. Paw withdrawal threshold testing revealed either 2 Hz:54 Hz or 25 Hz:40 Hz as the most effective stimulation pair, depending on mediolateral vs rostrocaudal electrode configuration and vertebral level of stimulation, with rodent responder rates up to 100%. Overall, dfSCS is a promising approach to improving the efficacy of SCS for neuropathic pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.